» Articles » PMID: 12381649

Arterial Endothelial Function is Impaired in Treated Depression

Overview
Journal Heart
Date 2002 Oct 17
PMID 12381649
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine whether patients with treated depression but no other risk factors for coronary heart disease (CHD) have abnormal arterial endothelial function, an abnormality that is common to other acquired risk factors for CHD.

Design: Case-control study.

Setting: Secondary care departments of cardiology and psychiatry in a single centre and the surrounding community.

Participants: Patients with treated depression and matched healthy controls, aged 18-55 years, without conventional acquired risk factors for CHD. These were recruited from local community mental health clinics, general practices, and patient support groups, and through posters placed in public areas of the hospital. Patients had major depression as defined in the American Psychiatric Association's Diagnostic and statistical manual of mental disorders, fourth edition. Fifteen patients and 12 controls were recruited, and 12 patients and 10 controls completed the study.

Outcomes: Brachial artery flow mediated dilatation and baroreflex sensitivity.

Results: Arterial endothelial function measured by flow mediated dilatation was impaired in depression (mean (SEM) -0.7% (1.7%)) compared with controls (5.7% (0.9%), p = 0.005 by non-paired t test). Baroreflex sensitivity did not differ significantly between the groups.

Conclusion: Arterial endothelial function is impaired in treated depression. This abnormality may contribute to the increased risk of CHD seen in depression.

Citing Articles

Unveiling shared therapeutic targets and pathological pathways between coronary artery disease and major depressive disorder through bioinformatics analysis.

Hu M, Tan R, Lu C, Zhou T, Wang Q, Liu T Sci Rep. 2024; 14(1):29365.

PMID: 39592804 PMC: 11599718. DOI: 10.1038/s41598-024-80920-2.


Association between depression and macrovascular disease: a mini review.

Zhao S, Zhu L, Yang J Front Psychiatry. 2023; 14:1215173.

PMID: 37457763 PMC: 10344456. DOI: 10.3389/fpsyt.2023.1215173.


Mental Health in Coronary Heart Disease (CHD) Patients: Findings from the UK Household Longitudinal Study (UKHLS).

Kang W, Malvaso A Healthcare (Basel). 2023; 11(10).

PMID: 37239650 PMC: 10218487. DOI: 10.3390/healthcare11101364.


Genetic liability to mental disorders in relation to the risk of hypertension.

Huangfu N, Lu Y, Ma H, Hu Z, Cui H, Yang F Front Cardiovasc Med. 2023; 10:1087251.

PMID: 36923957 PMC: 10008891. DOI: 10.3389/fcvm.2023.1087251.


Off-Target Effects of Antidepressants on Vascular Function and Structure.

Dimoula A, Fotellis D, Aivalioti E, Delialis D, Polissidis A, Patras R Biomedicines. 2022; 10(1).

PMID: 35052735 PMC: 8773150. DOI: 10.3390/biomedicines10010056.


References
1.
Musselman D, Evans D, Nemeroff C . The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998; 55(7):580-92. DOI: 10.1001/archpsyc.55.7.580. View

2.
Watkins L, Grossman P . Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J. 1999; 137(3):453-7. DOI: 10.1016/s0002-8703(99)70491-6. View

3.
Ferketich A, Schwartzbaum J, Frid D, Moeschberger M . Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med. 2000; 160(9):1261-8. DOI: 10.1001/archinte.160.9.1261. View

4.
Ariyo A, Haan M, Tangen C, Rutledge J, Cushman M, Dobs A . Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation. 2000; 102(15):1773-9. DOI: 10.1161/01.cir.102.15.1773. View

5.
Mangos G, Walker B, Kelly J, Lawson J, Webb D, Whitworth J . Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens. 2000; 13(11):1155-60. DOI: 10.1016/s0895-7061(00)01201-2. View